S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7177 +0.35%
PRE-MKT · 08:25 ET
Market ClerkRecap
Wed Nov 4 · pre-market3 signals today175 insider buys this week · $365.2MCIRO short report next: Nov 15The week ahead

KYNB

KYNTRA BIO, INC.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
4.31
−0.15 −3.36%
USD · close Nov 3

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $17.5MP/E 0.1DIV YIELD —FCF YIELD -218.10%REV TTM $4.6M −37.1%NET INCOME $183.2MNET DEBT $24.4M52W 4.31 – 11.03SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
No STOCK Act disclosure names KYNB.

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch KYNB. Know when insiders buy.
One email the day a filing lands. Free.